-
Signature
-
/s/ Kristen McVeety, as Attorney-in-Fact
-
Issuer symbol
-
CRWV
-
Transactions as of
-
02 Sep 2025
-
Net transactions value
-
-$5,244,849
-
Form type
-
4
-
Filing time
-
04 Sep 2025, 16:35:19 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Goldberg Chen |
SVP of Engineering |
C/O COREWEAVE, INC., 290 WEST MT. PLEASANT AVENUE, SUITE 4100, LIVINGSTON |
/s/ Kristen McVeety, as Attorney-in-Fact |
04 Sep 2025 |
0002058056 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$604,231 |
-6,614 |
-8.8% |
$91.36 |
68,444 |
02 Sep 2025 |
Direct |
F1, F2 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$2,182,488 |
-23,643 |
-35% |
$92.31 |
44,801 |
02 Sep 2025 |
Direct |
F1, F3 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$820,114 |
-8,794 |
-20% |
$93.26 |
36,007 |
02 Sep 2025 |
Direct |
F1, F4 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$663,187 |
-7,038 |
-20% |
$94.23 |
28,969 |
02 Sep 2025 |
Direct |
F1, F5 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$704,477 |
-7,394 |
-26% |
$95.28 |
21,575 |
02 Sep 2025 |
Direct |
F1, F6 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$270,351 |
-2,811 |
-13% |
$96.18 |
18,764 |
02 Sep 2025 |
Direct |
F1, F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: